Sign In
Buy DTIL
$6.04
-0.280 (-4.43%)
At Close: Jun 03, 2026
Analysts Are Bullish on Top Healthcare Stocks: Krystal Biotech (KRYS), Precision BioSciences (DTIL)
04:11pm, Tuesday, 10'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech (KRYS) and Precision BioSciences (DTIL)
Analysts Are Bullish on Top Healthcare Stocks: Krystal Biotech (KRYS), Precision BioSciences (DTIL)
04:11pm, Tuesday, 10'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Krystal Biotech
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
11:05am, Tuesday, 10'th Mar 2020
-Presented initial clinical data for lead allogeneic CAR T program PBCAR0191 for the treatment of NHL and B-ALL- -Implemented amendment to PBCAR0191 Phase 1/2a trial focused on.
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
New sell-side coverage - healthcare
12:37pm, Thursday, 05'th Mar 2020
10X Genomics (NASDAQ:TXG) initiated with Buy rating and $95 (23% upside) price target at Guggenheim.Abbott (NYSE:ABT) initiated with Buy rating at Citigroup. Shares down 1% premarket.Alcon (NYSE:ALC
CRISPR Therapeutics: A Review Of Its Clinical Pipeline And Progress
04:13pm, Sunday, 01'st Mar 2020
CRISPR Therapeutics is a gene-editing company focused on using CRISPR/Cas 9 in therapeutics areas such as hemoglobinopathies, immuno-oncology, regenerative medi
Precision BioSciences: Consider Taking Up A Small Position
04:26pm, Monday, 24'th Feb 2020
Precision BioSciences is advancing its allogeneic CAR Ts based on its ARCUS gene-editing platform. Interim data updates of its lead program was disappointing du
DURHAM, N.C., Feb. 21, 2020 -- Precision BioSciences, Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering,.
About to Buy Penny Stocks? Look at These 2 Companies First
01:45pm, Friday, 14'th Feb 2020
These healthcare stocks offer high risk and high reward, but they aren't nearly as risky as penny stocks.
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
08:14am, Wednesday, 12'th Feb 2020
CRISPR, capacity, and consolidation powered the cell and gene therapy space in 2019, but a proactive focus on patient access topped Falcon Therapeutics
Osage University Partners Promotes Kirsten Leute to Partner
03:14pm, Tuesday, 11'th Feb 2020
Osage University Partners, a Philadelphia-based venture capital firm, today announced the promotion of Kirsten Leute to Partner, University Relations.
Head-To-Head Contrast: Acorda Therapeutics (NASDAQ:ACOR) & Precision BioSciences (NASDAQ:DTIL)
07:10am, Saturday, 25'th Jan 2020
Acorda Therapeutics (NASDAQ:ACOR) and Precision BioSciences (NASDAQ:DTIL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the st
Analysts Offer Insights on Healthcare Companies: Precision BioSciences (NASDAQ: DTIL) and Ironwood Pharma (NASDAQ: IRWD)
12:21pm, Tuesday, 21'st Jan 2020
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on Precision BioSciences (
DTIL
–
Research Report
) and Ironwood Pharma (
IRWD
–
Research Report
).
Pr
These Gene-Editing Pioneers Are Making Bold Bets in Agriculture
02:00pm, Saturday, 18'th Jan 2020
Investors shouldn't forget that the world of biotech extends beyond biopharmaceuticals.
Precision BioSciences, Inc. (DTIL), a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS® platform, today announced that the U.S. Food and
